Abstract
Cellular protein degradation systems are necessary to avoid the accumulation of misfolded or damaged proteins. Deficiency in these systems might cause to partial degradation of misfolded proteins and generation of amyloidogenic fragments. Protein misfolding is believed to be the primary cause of neurodegenerative disorders such as Alzheimer’s disease (AD). In this study, we investigate effect of two anionic peptide fragments including, an acidic fragment of human Aβ (Aβ1–11) and a phosphorylated fragment of β-Casein (Tetraphosphopeptide), on tau protein aggregation. According to our results, these peptide fragments, induced tau fibrillization in vitro. In sum, we suggest that structural and conformational characters of inducer are as important as charge distribution on anionic inducer molecules however more experiments would be need to exactly confirm this suggestion.
Keywords: Aggregation, β-Casein Tetraphosphopeptide, Human Aβ1-11, Protein misfolding, Tau.
Protein & Peptide Letters
Title:The Role of Anionic Peptide Fragments in 1N4R Human Tau Protein Aggregation
Volume: 21 Issue: 6
Author(s): Mohammad Ali Nasiri Khalili, Gholamhossein Riazi, Shahin Ahmadian, Reza Khodarahmi, Sirus Khodadadi, Ali Afrasiabi, Oveis Karima, Farzad Mokhtari and Elham Hoveizi
Affiliation:
Keywords: Aggregation, β-Casein Tetraphosphopeptide, Human Aβ1-11, Protein misfolding, Tau.
Abstract: Cellular protein degradation systems are necessary to avoid the accumulation of misfolded or damaged proteins. Deficiency in these systems might cause to partial degradation of misfolded proteins and generation of amyloidogenic fragments. Protein misfolding is believed to be the primary cause of neurodegenerative disorders such as Alzheimer’s disease (AD). In this study, we investigate effect of two anionic peptide fragments including, an acidic fragment of human Aβ (Aβ1–11) and a phosphorylated fragment of β-Casein (Tetraphosphopeptide), on tau protein aggregation. According to our results, these peptide fragments, induced tau fibrillization in vitro. In sum, we suggest that structural and conformational characters of inducer are as important as charge distribution on anionic inducer molecules however more experiments would be need to exactly confirm this suggestion.
Export Options
About this article
Cite this article as:
Khalili Ali Nasiri Mohammad, Riazi Gholamhossein, Ahmadian Shahin, Khodarahmi Reza, Khodadadi Sirus, Afrasiabi Ali, Karima Oveis, Mokhtari Farzad and Hoveizi Elham, The Role of Anionic Peptide Fragments in 1N4R Human Tau Protein Aggregation, Protein & Peptide Letters 2014; 21 (6) . https://dx.doi.org/10.2174/0929866521666131223120713
DOI https://dx.doi.org/10.2174/0929866521666131223120713 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Plant Bioactive Peptides: Current Status and Prospects Towards Use on Human Health
Protein & Peptide Letters An Update on Drug Interactions with the Herbal Medicine Ginkgo biloba
Current Drug Metabolism Kinases as Targets for Parkinson's Disease: From Genetics to Therapy
CNS & Neurological Disorders - Drug Targets Possible Physiopathological Effects of the Transglutaminase Activity on the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration
Current Neuropharmacology The Antimalarial Drug Pyronaridine Inhibits Topoisomerase II in Breast Cancer Cells and Hinders Tumor Progression In Vivo
Clinical Cancer Drugs The Contribution of Buckwheat Genetic Resources to Health and Dietary Diversity
Current Genomics Nitroxyl (HNO): A Possible Strategy for Fighting Cancer
Current Topics in Medicinal Chemistry Current and Potential Treatments for Cervical Cancer
Current Cancer Drug Targets Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
Current Medicinal Chemistry A Review on Chitosan in Drug Delivery for Treatment of Neurological and Psychiatric Disorders
Current Pharmaceutical Biotechnology The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance
Current Cancer Drug Targets The DDX3 Subfamily of the DEAD Box Helicases: Divergent Roles as Unveiled by Studying Different Organisms and In Vitro Assays
Current Medicinal Chemistry Mitochondrial Permeability Transition Pore as a Suitable Targ e t for Neuroprotective Agents Against Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Mutations of Chromatin Structure Regulating Genes in Human Malignancies
Current Protein & Peptide Science Subject Index to Volume 3
Current Drug Targets - CNS & Neurological Disorders Microdissection and the Study of Cancer Pathways
Current Molecular Medicine Dynamic Crosstalk between GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription and Human Disease
Current Signal Transduction Therapy Impact of Diabetes in Blood-Testis and Blood-Brain Barriers: Resemblances and Differences
Current Diabetes Reviews Molecular Basis for the Neuroprotective Properties of FKBP-Binding Immunophilin Ligands
Current Medicinal Chemistry - Central Nervous System Agents